NR3C1 and neoplasm: With the growing body of evidence related to the potential correlation of GR with prognosis and response to therapy, as suggested earlier, the assessment of GR (and other steroid receptors) status in tumor tissue (quadruple and/or quintuple with AR) may add further possibilities for patient’ classification in order to select that best therapeutical approach, i.e., endocrine agonist/antagonist therapies and chemotherapy [3].